Immuneering's total assets for Q4 2025 were $231.99M, a decrease of -3.76% from the previous quarter. IMRX total liabilities were $13.50M for the fiscal quarter, a 3.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.